MedPath
NMPA Approval

Baricitinib Tablets

国药准字HJ20190039

April 29, 2024

H20190039

Drug Information

巴瑞替尼片

艾乐明

片剂

2mg(以C₁₆H₁₇N₇O₂S计)

化学药品

April 29, 2024

April 28, 2029

Company Information

Applicant Company

Papendorpseweg 83,3528 BJ Utrecht, The Netherlands

Manufacturing Company

12.6 KM, 65th Infantry Road, Carolina, Puerto Rico(PR) 00985, USA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

巴瑞替尼片 - NMPA 批准文号 | MedPath